Asset Dedication LLC’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $623K | Buy |
2,261
+132
| +6% | +$37.3K | 0.04% | 219 |
|
|
2026
Q1 | $568K | Buy |
2,129
+1,016
| +91% | +$281K | 0.04% | 214 |
|
|
2025
Q4 | $306K | Sell |
1,113
-723
| -39% | -$203K | 0.02% | 263 |
|
|
2025
Q3 | $529K | Sell |
1,836
-679
| -27% | -$201K | 0.04% | 222 |
|
|
2025
Q2 | $831K | Buy |
2,515
+1,222
| +95% | +$394K | 0.06% | 179 |
|
|
2025
Q1 | $425K | Sell |
1,293
-126
| -9% | -$38K | 0.03% | 217 |
|
|
2024
Q4 | $392K | Buy |
1,419
+266
| +23% | +$84.8K | 0.03% | 225 |
|
|
2024
Q3 | $399K | Sell |
1,153
-1
| -0.1% | -$344 | 0.03% | 257 |
|
|
2024
Q2 | $382K | Buy |
1,154
+15
| +1% | +$5.17K | 0.03% | 253 |
|
|
2024
Q1 | $406K | Buy |
1,139
+208
| +22% | +$68.5K | 0.03% | 239 |
|
|
2023
Q4 | $275K | Sell |
931
-410
| -31% | -$120K | 0.02% | 265 |
|
|
2023
Q3 | $378K | Buy |
1,341
+511
| +62% | +$146K | 0.03% | 243 |
|
|
2023
Q2 | $227K | Buy |
830
+260
| +46% | +$67.7K | 0.02% | 289 |
|
|
2023
Q1 | $138K | Buy |
570
+36
| +7% | +$10.5K | 0.01% | 332 |
|
|
2022
Q4 | $172K | Sell |
534
-18
| -3% | -$5.7K | 0.02% | 313 |
|
|
2022
Q3 | $148K | Buy |
+552
| New | +$155K | 0.02% | 313 |
|
|
2022
Q2 | – | Sell |
-538
| Closed | -$125K | – | 567 |
|
|
2022
Q1 | $125K | Buy |
538
+11
| +2% | +$2.58K | 0.01% | 337 |
|
|
2021
Q4 | $120K | Sell |
527
-34
| -6% | -$7.23K | 0.01% | 315 |
|
|
2021
Q3 | $112K | Buy |
561
+26
| +5% | +$5.65K | 0.01% | 311 |
|
|
2021
Q2 | $127K | Sell |
535
-71
| -12% | -$17.7K | 0.02% | 292 |
|
|
2021
Q1 | $149K | Sell |
606
-55
| -8% | -$12.3K | 0.03% | 250 |
|
|
2020
Q4 | $139K | Sell |
661
-92
| -12% | -$18K | 0.03% | 269 |
|
|
2020
Q3 | $129K | Buy |
753
+62
| +9% | +$10.9K | 0.03% | 261 |
|
|
2020
Q2 | $130K | Sell |
691
-2
| -0.3% | -$379 | 0.04% | 236 |
|
|
2020
Q1 | $122K | Sell |
693
-201
| -22% | -$39K | 0.04% | 235 |
|
|
2019
Q4 | $184K | Sell |
894
-502
| -36% | -$92K | 0.05% | 176 |
|
|
2019
Q3 | $212K | Buy |
1,396
+1,257
| +904% | +$205K | 0.07% | 159 |
|
|
2019
Q2 | $22K | Sell |
139
-147
| -51% | -$23K | 0.01% | 360 |
|
|
2019
Q1 | $45K | Sell |
286
-50
| -15% | -$9.13K | 0.02% | 282 |
|
|
2018
Q4 | $66K | Buy |
336
+286
| +572% | +$59.7K | 0.03% | 243 |
|
|
2018
Q3 | $10K | Hold |
50
| – | – | ﹤0.01% | 436 |
|
|
2018
Q2 | $8K | Hold |
50
| – | – | ﹤0.01% | 467 |
|
|
2018
Q1 | $8K | Hold |
50
| – | – | ﹤0.01% | 394 |
|
|
2017
Q4 | $10K | Hold |
50
| – | – | ﹤0.01% | 354 |
|
|
2017
Q3 | $9K | Hold |
50
| – | – | ﹤0.01% | 297 |
|
|
2017
Q2 | $8K | Hold |
50
| – | – | ﹤0.01% | 318 |
|
|
2017
Q1 | $7K | Hold |
50
| – | – | ﹤0.01% | 319 |
|
|
2016
Q4 | $7K | Hold |
50
| – | – | ﹤0.01% | 316 |
|
|
2016
Q3 | $7K | Buy |
+50
| New | +$6.53K | ﹤0.01% | 307 |
|
|
2016
Q2 | – | Sell |
-7
| Closed | -$1K | – | 362 |
|
|
2016
Q1 | $1K | Sell |
7
-35
| -83% | -$4.81K | ﹤0.01% | 387 |
|
|
2015
Q4 | $6K | Buy |
+42
| New | +$5.77K | ﹤0.01% | 442 |
|
Other funds holding CI
Asset Dedication LLC's CI Position: Q2 2026 in Review
Asset Dedication LLC increased its Cigna (CI) stake by 6.2% in Q2 2026, buying an estimated $37.3K and bringing the position to 2,261 shares worth $623K. The position accounts for 0.04% of the portfolio, ranked #219.
Asset Dedication LLC first reported a position in CI in Q4 2015 and has held it in 41 quarters since. The position peaked at $831K in Q2 2025. 1,692 funds tracked by Wall St. Rank hold CI as of Q2 2026.
- Asset Dedication LLC held 2,261 shares of Cigna worth $623K as of Q2 2026.
- Asset Dedication LLC bought 132 Cigna shares in Q2 2026, an estimated $37.3K.
- Cigna made up 0.04% of Asset Dedication LLC's portfolio in Q2 2026, its #219 holding.
- Asset Dedication LLC first reported a position in Cigna in Q4 2015 and has held it in 41 quarters since.
- Asset Dedication LLC's Cigna position peaked at $831K in Q2 2025.
- 1,692 funds tracked by Wall St. Rank held Cigna as of Q2 2026.
Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.